SCHEMBL3636340

SCHEMBL3636340

COCCCS(=O)(=O)c1ccc(-c2ccc(CCn3cccc3C)cc2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 4/20 0.57
HRH3 Q9Y5N1 2/20 0.57
ALDH1A1 P00352 4/20 0.39
LMNA P02545 2/20 0.39
HPGD P15428 2/20 0.39
KDM4E B2RXH2 1/20 0.39
NPC1 O15118 1/20 0.39
MAPT P10636 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HTT P42858 1/20 0.39
CYP3A4 P08684 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
HDAC1 Q13547 1/20 0.34
HDAC8 Q9BY41 1/20 0.34
MMP3 P08254 1/20 0.34
FDFT1 P37268 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4115151 0.78 KCNH2 (0.39) KCNH2HRH3
SCHEMBL12863267 0.78 HRH3 (0.69) KCNH2HRH3
SCHEMBL12855839 0.78 KCNH2 (0.59) KCNH2HRH3ALDH1A1LMNAHPGD
SCHEMBL1938454 0.76 KCNH2 (0.58) KCNH2HRH3ALDH1A1LMNAHPGD
SCHEMBL1128041 0.76 KCNH2 (0.58) KCNH2HRH3ALDH1A1LMNAHPGD
SCHEMBL1938557 0.76 KCNH2 (0.58) KCNH2HRH3ALDH1A1LMNAHPGD
SCHEMBL13168396 0.76 KCNH2 (0.64) KCNH2HRH3
SCHEMBL12863268 0.75 KCNH2 (0.55) KCNH2HRH3ALDH1A1LMNAHPGD
SCHEMBL1128229 0.74 KCNH2 (0.56) KCNH2HRH3ALDH1A1LMNAHPGD
SCHEMBL1128049 0.73 KCNH2 (0.54) KCNH2HRH3ALDH1A1LMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2155668-A2 CRYSTALLINE FORMS OF (R)-1-{2-Ý4'- (3-METHOXY-PROPANE-1- SULFONYL)-BIPHENYL-4-YL¨-ETHYL}-2-METHYL-PYRROLIDINE, AND COMPOSITIONS, AND METHODS RELATED THERETO Arena Pharmaceuticals, Inc. (US) 2010-02-24 EP disclosed
WO-2008153958-A2 CRYSTALLINE FORMS OF (R)-1-{2-[4'- (3-METHOXY-PROPANE-1- SULFONYL)-BIPHENYL-4-YL]-ETHYL}-2-METHYL-PYRROLIDINE, AND COMPOSITIONS, AND METHODS RELATED THERETO ARENA PHARMACEUTICALS, INC. (US) 2008-12-18 WO disclosed